Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Sullivan John F, Directeur. Director active across 1 company, notably TransMedics Group, Inc.. Aggregated, 1 reports have been logged. Activity tracked since 30 August 2021. The latest transaction was filed on 30 August 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
John F. Sullivan is the Vice President of Quality & Engineering at TransMedics Group, Inc. He oversees operations related to quality and engineering, ensuring that products meet the highest standards. His expertise is essential in ensuring compliance and innovation.